Clinical Trial Update: STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating anticoagulation strategies in patients with cancer-associated thrombosis and thrombocytopenia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-associated Thrombosis
• Thrombocytopenia

Snippet

Sponsor: Tzu-Fei Wang | Conditions: Cancer-associated Thrombosis, Thrombocytopenia | Phase 4 | Status: RECRUITING